WIRE — The policy, effective from August 1, 2026 onwards,aims to boost production of generic medicines in the US.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.